The EU X CT Initiative, a pan European public private partnership aiming to facilitating cross-border access to clinical trials, launched its final practical recommendations at its Public Stakeholder Conference held in Brussels on 24 June. The hybrid event brought together key stakeholders and policy makers who shared insights, experiences and best practices for cross-border access to clinical trials across Europe. Over the past two years, members of the initiative collected information from multiple stakeholders on the regulatory, ethical, social security and organisational conditions, experiences and best practices for cross-border access to trials in many European countries. The data has been used to populate a publicly accessible EU-X-CT website and to draft recommendations on various aspects of cross-border trials, which were published for public consultation in February 2025. This document was developed in consultation with over 100 members from 32 countries. More information about the initiative and the recommendations can be found here: https://eu-x-ct.eu/
